Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply
N Engl J Med
.
2023 Sep 21;389(12):1152-1153.
doi: 10.1056/NEJMc2309399.
Authors
Jason R Westin
1
,
Christina To
2
,
Frederick L Locke
3
Affiliations
1
University of Texas M.D. Anderson Cancer Center, Houston, TX jwestin@mdanderson.org.
2
Kite, Santa Monica, CA.
3
Moffitt Cancer Center, Tampa, FL.
PMID:
37733323
DOI:
10.1056/NEJMc2309399
No abstract available
Publication types
Letter
Comment
MeSH terms
Antigens, CD19* / therapeutic use
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell*
Substances
axicabtagene ciloleucel
Antigens, CD19